CytomX Therapeutics Inc (STU:6C1)
€ 2.76 -0.16 (-5.61%) Market Cap: 600.29 Mil Enterprise Value: 321.73 Mil PE Ratio: 0 PB Ratio: 2.32 GF Score: 42/100

CytomX Therapeutics Inc (STU:6C1) Transcripts

  • 1